Lattice radiation with immunotherapy for advanced tumors
This trial tests a new way to give radiation called lattice therapy together with immunotherapy drugs that help your immune system fight cancer. It is for people with advanced solid tumors that have grown or spread, with at least one large tumor that can be measured.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You have an advanced solid tumor that has come back or spread, but not in the brain.
- You have at least one large tumor (at least 5 cm in size) that can be seen on imaging.
- You have already tried at least one standard treatment (like chemotherapy or targeted therapy), and it stopped working or you couldn't tolerate it.
- Your blood tests and organ function (like liver and kidneys) must be at certain levels.
- You have not had serious heart problems recently and can perform daily activities (ECOG 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation combined with immunotherapy for people with advanced solid tumors that are no longer responding to standard treatments or cannot tolerate them. The goal is to see if this combination can help control the disease.
This study tests a new way to deliver radiation called lattice therapy for people with large solid tumors that are causing symptoms. It aims to give a stronger radiation dose to help shrink the tumor and relieve discomfort.
This trial tests combining two types of radiation therapy with an immunotherapy drug for people with advanced solid tumors that have spread or come back. The goal is to see if this approach can help when standard treatments have stopped working or aren’t an option.
This trial tests a new way of giving radiation therapy called lattice radiotherapy (LRT) for people with large tumors that cannot be cured with standard treatments. It aims to deliver high doses of radiation to the center of the tumor while sparing surrounding healthy tissue, potentially controlling the tumor and improving quality of life.
This trial tests a special type of focused radiation therapy (called SBRT-Lattice) for large tumors in patients who can't benefit from surgery, chemotherapy, or standard radiation. The radiation uses a lattice pattern designed to treat the tumor while protecting healthy tissue nearby.
This trial studies a new radiation technique called SFRT combined with chemoimmunotherapy for people with stage III lung cancer that did not respond well enough to the first round of treatment. The goal is to see if this combination can make the cancer shrink more effectively.
Hear when a new Advanced Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.